Avivomed

Minneapolis, United States

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

$32.0M raised

Dec 2021

Series A

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avivomed

How much funding has Avivomed raised?

Avivomed has raised $32.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Where is Avivomed headquartered?

Avivomed is headquartered in Minneapolis, United States.

What does Avivomed do?

Avivomed engages in developing neuromodulation therapy intended to treat unmet clinical needs.

What stage is Avivomed at?

Avivomed is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2021.

MLA

"Avivomed — Funding & Investors." VCBacked, December 1, 2021, https://www.vcbacked.co/company/avivomed. Accessed July 2, 2026.

APA

VCBacked. (2021). Avivomed — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/avivomed

Wikipedia (cite web)

{{cite web |title=Avivomed — Funding & Investors |url=https://www.vcbacked.co/company/avivomed |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2021.